A new indication for the antibiotic moxifloxacin HCl (Avelox, made by Bayer Pharmaceuticals Corp.) was approved by the FDA on May 19, allowing its use in the treatment of community-acquired pneumonia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback